Design of controlled release inert matrices of Naltrexone hydrochloride (cas 16676-29-2) based on percolation concepts
-
Add time:09/27/2019 Source:sciencedirect.com
The percolation theory is a statistical theory able to study chaotic or disordered systems that has been applied in the pharmaceutical field since 1987. Through the application of this theory, the design of controlled release inert matrices has been improved. The aim of the present paper is to estimate the percolation thresholds, the most important concept of the percolation theory, which characterise the release behaviour of controlled release inert matrices of Naltrexone hydrochloride (cas 16676-29-2). Matrix tablets were prepared using naltrexone hydrochloride as a potent narcotic antagonist and Eudragit® RS-PM as matrix forming material in different ratios, keeping constant the drug and excipient particle sizes. In vitro release assays were carried out exposing only one side of the tablets to the dissolution medium. The drug percolation threshold was estimated using different methods. The method of Leuenberger and Bonny gives 31.11±7.95% v/v as the critical porosity, which corresponds to a percolation range from 12 to 20% (w/w) of drug content. The release profiles and the release kinetics are in agreement with this result. A change in the exponent k (from 0.29 to 0.57) has been found in this region. Using scanning electron microscopy, the percolation threshold has been observed in a higher concentration range (20–35% w/w). This fact can be attributed to the low accuracy of the visual methods, mainly due to the extrapolation from 2D to 3D systems. If a percolating cluster is observed in two dimensions, the percolation threshold of the 3D system will be already clearly exceeded. The excipient percolation threshold is estimated between 25.4 and 31.1% (v/v) based on the release profiles and the analysis of the release kinetics.
We also recommend Trading Suppliers and Manufacturers of Naltrexone hydrochloride (cas 16676-29-2). Pls Click Website Link as below: cas 16676-29-2 suppliers
Prev:Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice
Next:Enzymatic reaction of β-N-methylaminoalanine with l-amino acid oxidase) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice09/26/2019
- Original articleSimultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine09/25/2019
- Research ArticlesStructural characterization of anhydrous naloxone‐ and Naltrexone hydrochloride (cas 16676-29-2) by high resolution laboratory X‐ray powder diffraction and thermal analysis09/24/2019
- Niosomes and discomes for ocular delivery of Naltrexone hydrochloride (cas 16676-29-2): Morphological, rheological, spreading properties and photo-protective effects09/10/2019
- Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-Naltrexone hydrochloride (cas 16676-29-2): Fabrication, mechanical properties, mucoadhesion, tolerability and stability studies09/09/2019
- Hydrogels for diabetic eyes: Naltrexone loading, release profiles and cornea penetration09/08/2019
- Pharmaceutics, Preformulation and Drug DeliveryDesign and Evaluation of Controlled-Release Niosomes and Discomes for Naltrexone hydrochloride (cas 16676-29-2) Ocular Delivery09/07/2019
- In-vivo study of Naltrexone hydrochloride (cas 16676-29-2) release from an in-situ forming PLGA-PEG-PLGA system in the rabbit09/06/2019
-
Health and Chemical more >